Andrew K Godwin Selected Research

Platinum

12/2018	Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.
3/2018	Developing a genetic signature to predict drug response in ovarian cancer.
2/2017	Exosomes as mediators of platinum resistance in ovarian cancer.
1/2013	Epimorphin-induced MET sensitizes ovarian cancer cells to platinum.
6/2011	A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.
5/2008	Molecular mechanisms of action of imatinib mesylate in human ovarian cancer: a proteomic analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew K Godwin Research Topics

Disease

140	Neoplasms (Cancer) 08/2022 - 05/2002
64	Breast Neoplasms (Breast Cancer) 11/2022 - 02/2003
50	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 01/2002
22	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018 - 08/2003
19	Carcinoma (Carcinomatosis) 12/2020 - 10/2002
16	Carcinogenesis 01/2018 - 08/2003
14	Ovarian Epithelial Carcinoma 04/2020 - 04/2007
9	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2002
8	Triple Negative Breast Neoplasms 07/2022 - 02/2017
7	Endometrial Neoplasms (Endometrial Cancer) 11/2014 - 06/2009
5	Ewing Sarcoma (Sarcoma, Ewing) 08/2020 - 01/2017
5	Aneuploidy (Aneuploid) 08/2011 - 07/2007
4	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 11/2007
4	Pathologic Complete Response 07/2022 - 02/2017
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 09/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 08/2007
3	Ductal Carcinoma 01/2017 - 02/2012
3	Leukemia 01/2017 - 05/2002
3	Disease Progression 12/2012 - 02/2008
3	Lung Neoplasms (Lung Cancer) 04/2011 - 05/2002
2	Residual Neoplasm 01/2022 - 01/2020
2	Infections 01/2022 - 11/2021
2	Genomic Instability 01/2021 - 08/2011
2	Ascites 04/2020 - 01/2007
2	Chromosomal Instability (Chromosome Stability) 08/2017 - 01/2014
2	Tuberous Sclerosis (Bourneville's Disease) 03/2017 - 12/2004

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
30	Estrogen ReceptorsIBA 11/2022 - 03/2006
25	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
16	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2003
15	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 08/2003
14	Progesterone Receptors (Progesterone Receptor)IBA 07/2022 - 01/2007
12	Pharmaceutical PreparationsIBA 03/2018 - 09/2002
11	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2007
10	Transcription Factors (Transcription Factor)IBA 08/2022 - 06/2009
10	Biological ProductsIBA 11/2021 - 02/2006
9	Messenger RNA (mRNA)IBA 01/2022 - 05/2002
9	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2008
9	Small Interfering RNA (siRNA)IBA 12/2015 - 04/2005
8	Hormones (Hormone)IBA 01/2022 - 01/2006
8	ErbB Receptors (EGF Receptor)IBA 12/2020 - 08/2002
6	Formaldehyde (Formol)FDA Link 01/2022 - 03/2014
6	PlatinumIBA 12/2018 - 05/2008
6	Insulin-Like PeptidesIBA 01/2013 - 06/2008
5	Estrogens (Estrogen)FDA Link 07/2022 - 01/2011
5	ParaffinIBA 01/2022 - 02/2012
5	taxaneIBA 01/2021 - 05/2008
5	Phosphotransferases (Kinase)IBA 03/2016 - 08/2002
5	Epidermal Growth Factor (EGF)IBA 09/2015 - 08/2002
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 11/2014
4	AnthracyclinesIBA 01/2021 - 02/2017
3	NucleotidesIBA 11/2022 - 01/2014
3	ProteomeIBA 01/2022 - 02/2005
3	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 10/2011
3	CytokinesIBA 02/2021 - 06/2009
3	olaparibIBA 01/2021 - 01/2019
3	SteroidsIBA 10/2020 - 01/2006
3	Phenobarbital (Luminal)FDA Link 01/2020 - 06/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018 - 07/2013
3	CollagenIBA 12/2017 - 05/2002
3	Aurora Kinase AIBA 08/2017 - 07/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 11/2006
3	EnzymesIBA 11/2015 - 01/2007
3	Dasatinib (BMS 354825)FDA Link 01/2015 - 03/2010
3	LigandsIBA 02/2014 - 08/2007
3	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 02/2007
3	Gefitinib (Iressa)FDA Link 06/2013 - 08/2005
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2013 - 06/2009
3	Peptide Hydrolases (Proteases)FDA Link 04/2011 - 02/2004
3	Platelet-Derived Growth Factor alpha ReceptorIBA 10/2008 - 05/2005
2	Conditioned Culture MediaIBA 02/2021 - 01/2007
2	Mitogen-Activated Protein KinasesIBA 02/2021 - 06/2009
2	entinostat (MS 275)IBA 01/2021 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 04/2020
2	Progesterone FDA LinkGeneric 12/2020 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 12/2020 - 11/2012
2	human ERBB2 proteinIBA 01/2020 - 01/2017
2	ChromatinIBA 01/2020 - 07/2009
2	AntigensIBA 01/2020 - 01/2011
2	IntegrinsIBA 01/2020 - 02/2014
2	Nucleic AcidsIBA 12/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 03/2011
2	EWS-FLI fusion proteinIBA 01/2019 - 12/2018
2	Docetaxel (Taxotere)FDA Link 12/2018 - 02/2017
2	Ligases (Synthetase)IBA 11/2018 - 12/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 06/2011
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2017 - 01/2014
2	trans-sodium crocetinate (crocetin)IBA 03/2017 - 12/2004
2	Thioredoxin-Disulfide ReductaseIBA 01/2017 - 07/2013
2	Auranofin (Ridaura)FDA Link 01/2017 - 07/2013
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 11/2015
2	ProgranulinsIBA 08/2016 - 02/2012

Therapy/Procedure

34	Therapeutics 07/2022 - 11/2005
13	Drug Therapy (Chemotherapy) 07/2022 - 09/2002
4	Neoadjuvant Therapy 07/2022 - 12/2018
4	Ovariectomy (Oophorectomy) 07/2008 - 12/2003
2	Chemoprevention 12/2017 - 01/2010